RealFeedApp U.S. cancer death rate dropped by about a third since 1990
In January 2025, a New York patient received access to sunvozertinib, a drug approved by the FDA, after a doctor suggested seeking it abroad due to lack of local clinical trial options.
- Field
- cancer research
- What they did
- Patients in the US, who lack access to approved drugs, are turning to China for cutting-edge cancer treatments.
- Why it matters
- This gives them access to medicines not yet approved by the FDA, which can save lives when standard therapy has failed.
#sunvozertinib#fda#clinical trial#cancer treatment#us healthcare
